Showing results (721-730 of 1,838) with videos related to
Sort By:
Pageof 184
ESMO Open|February 2, 2023
Macrophage and monocyte subsets as new therapeutic targets in cancer immunotherapyB Fendl, A S Berghoff, M Preusser, et al.ESMO Open|February 3, 2023
Design, power, and alpha levels in randomized phase II oncology trialsA Haslam, T Olivier, V PrasadESMO Open|November 18, 2022
Health-related quality of life in breast cancer patients treated with CDK4/6 inhibitors: a systematic reviewV Di Lauro, G Barchiesi, F Martorana, et al.ESMO Open|February 15, 2023
Neuromuscular and cardiac adverse events associated with immune checkpoint inhibitors: pooled analysis of individual cases from multiple institutions and literatureA Boutros, A Bottini, G Rossi, et al.ESMO Open|February 23, 2023
Real-world data in oncology: a questionnaire-based analysis of the academic research landscape examining the policies and experiences of the cancer cooperative groupsR Saesen, D Lacombe, I HuysESMO Open|February 26, 2023
Precision oncology for BRAF-mutant cancers with BRAF and MEK inhibitors: from melanoma to tissue-agnostic therapyM A Gouda, V SubbiahESMO Open|February 25, 2025
Adolescent and young adult (AYA) patient involvement and engagement in European health care and research projects: expanding the scope of patient advocacyU Košir, F Lysen, N Unterecker, et al.ESMO Open|February 18, 2025
The genomic landscape of metastatic clear-cell renal cell carcinoma and its prognostic value: a comprehensive analysis of a large real-world clinico-genomic databaseM Rizzo, G Pezzicoli, C Porta, et al.ESMO Open|February 22, 2025
A phase I, first-in-human trial of KO-947, an ERK1/2 inhibitor, in patients with advanced solid tumorsA M Schram, V Boni, A A Adjei, et al.ESMO Open|February 15, 2025
Palbociclib exposure in relation to efficacy and toxicity in patients with advanced breast cancerS M Buijs, M I Mohmaed Ali, E Oomen-de Hoop, et al.Pageof 184